Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Artificial Intelligence/Machine Learning-Driven Small Molecule Repurposing via Off-Target Prediction and Transcriptomics. | Toxics | 2023 | 37888725 | PubTator, text mining | PubMed |
| Re-Emergence of HMPV in Gwangju, South Korea, after the COVID-19 Pandemic. | Pathogens | 2023 | 37887734 | PubTator, text mining | PubMed |
| Management of Priapism: Results of a Nationwide Survey and Comparison with International Guidelines. | Urol Res Pract | 2023 | 37877823 | PubTator, text mining | PubMed |
| A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways. | Cell Commun Signal | 2023 | 37845748 | PubTator, text mining | PubMed |
| A Method for the Precise Coordinate Determination of an Inaccessible Location. | Sensors (Basel) | 2023 | 37837028 | PubTator, text mining | PubMed |
| Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery. | Molecules | 2023 | 37836750 | PubTator, text mining | PubMed |
| Effect of Dimeric Disintegrins Isolated from Vipera lebetina obtusa Venom on Glioblastoma Cellular Responses. | Cancers (Basel) | 2023 | 37835499 | PubTator, text mining | PubMed |
| Structural basis of dimerization of chemokine receptors CCR5 and CXCR4. | Nat Commun | 2023 | 37833254 | PubTator, text mining | PubMed |
| Disruption of the productive encounter complex results in dysregulation of DIAPH1 activity. | J Biol Chem | 2023 | 37832872 | PubTator, text mining | PubMed |
| Progress of research on PD-1/PD-L1 in leukemia. | Front Immunol | 2023 | 37822924 | PubTator, text mining | PubMed |
| Sequence-directed concentration of G protein-coupled receptors in COPII vesicles. | iScience | 2023 | 37810244 | PubTator, text mining | PubMed |
| Cannabidiol in sports: insights on how CBD could improve performance and recovery. | Front Pharmacol | 2023 | 37808192 | PubTator, text mining | PubMed |
| Dynamic ultrasound molecular-targeted imaging of senescence in evaluation of lapatinib resistance in HER2-positive breast cancer. | Cancer Med | 2023 | 37792675 | PubTator, text mining | PubMed |
| The P2X7 Receptor in Autoimmunity. | Int J Mol Sci | 2023 | 37762419 | PubTator, text mining | PubMed |
| The Role of Regulatory T Cells in Cancer Treatment Resistance. | Int J Mol Sci | 2023 | 37762416 | PubTator, text mining | PubMed |
| Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity. | Int J Mol Sci | 2023 | 37762006 | PubTator, text mining | PubMed |
| Pharmacology of Adenosine Receptors: Recent Advancements. | Biomolecules | 2023 | 37759787 | PubTator, text mining | PubMed |
| Functional Interaction between Adenosine A2A and mGlu5 Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGlu5R Binding in Mouse Hippocampus and Neuroblastoma Cell Line. | Biomolecules | 2023 | 37759748 | PubTator, text mining | PubMed |
Differential Gene Expression in Activated Microglia Treated with Adenosine A2A Receptor Antagonists Highlights Olfactory Receptor 56 and T-Cell Activation GTPase-Activating Protein 1 as Potential Biomarkers of the Polarization of Activated Microglia. | Cells | 2023 | 37759436 | PubTator, text mining | PubMed |
| The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer. | Front Immunol | 2023 | 37753093 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=9